CRWV (NASDAQ: CRWV) insider files Form 144 for $12.0M share sale

Rhea-AI Filing Summary

A holder of common shares has filed a Rule 144 notice to sell 154,479 shares of the issuer’s common stock through Morgan Stanley Smith Barney, with an aggregate market value of $12,040,093.26. The common stock is listed on NASDAQ, and the issuer has 386,401,201 shares outstanding.

The shares to be sold were acquired on 12/27/2023 as founder shares directly from the issuer, in the same amount of 154,479. The filing also lists prior sales of the issuer’s common stock during the past three months under Rule 10b5-1 trading plans and other transactions, including sales attributed to Brian Venturo, West Clay Capital LLC, YOLO APV Trust, YOLO ECV Trust, and a non-affiliate donee, each with specified share amounts and gross proceeds.

Insights

Securities law analyst

Form 144 discloses planned founder-share sales and recent 10b5-1 activity.

This notice states that a holder of founder shares plans to sell 154,479 common shares under Rule 144, with an aggregate market value of $12,040,093.26. The shares were acquired on 12/27/2023 as founder shares from the issuer, matching the amount now proposed for sale, and will be sold through Morgan Stanley Smith Barney on NASDAQ, where 386,401,201 common shares are outstanding.

The document also summarizes recent sales of the issuer’s common stock over the past three months. These include multiple Rule 10b5-1 plan sales attributed to Brian Venturo, West Clay Capital LLC, YOLO APV Trust, and YOLO ECV Trust, as well as a transaction for a non-affiliate donee, each with detailed share counts and gross proceeds. The representation section reiterates that the seller does not know of undisclosed material adverse information about the issuer’s operations, consistent with Rule 144 and Rule 10b5-1 requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	154479	12040093.26	386401201	01/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/27/2023	Founders Shares	Issuer			154479	12/27/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRIAN VENTURO 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/06/2026	52473	3996070.82
BRIAN VENTURO 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	65940	4785362.54
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/24/2025	281250	22319662.50
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/10/2025	281250	24679190.63
10b5-1 Sales for YOLO APV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/01/2025	32807	2459042.12
10b5-1 Sales for YOLO ECV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/01/2025	32799	2458006.26
Non-Affiliate Donee 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/01/2025	33500	2373140.00
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/26/2025	281250	20936896.88
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/12/2025	281250	24630103.13
10b5-1 Sales for YOLO APV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/03/2025	14958	1913648.74
10b5-1 Sales for YOLO ECV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/03/2025	14958	1913714.55
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	10/29/2025	281250	38755378.13
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	10/15/2025	154479	21390061.62

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for CRWV disclose?

It discloses a planned sale of 154,479 common shares under Rule 144, with an aggregate market value of $12,040,093.26, to be sold through Morgan Stanley Smith Barney on NASDAQ.

How many CRWV shares are proposed to be sold and what is their value?

The notice covers 154,479 common shares with an aggregate market value of $12,040,093.26, based on the market price referenced in the filing.

When and how were the CRWV shares to be sold originally acquired?

The 154,479 common shares were acquired on 12/27/2023 as founder shares from the issuer, with the same amount shown as acquired and now being proposed for sale.

What does the filing say about recent CRWV stock sales in the past three months?

It lists multiple sales of common stock over the past three months, including Rule 10b5-1 sales for Brian Venturo, West Clay Capital LLC, YOLO APV Trust, YOLO ECV Trust, and a non-affiliate donee, each with specific dates, share amounts, and gross proceeds.

How many CRWV shares are outstanding according to this filing?

The filing reports that there are 386,401,201 common shares outstanding for the issuer.

What representation does the seller make about CRWV in this Form 144?

By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.